NEW INFORMATION REGARDING UNCOMMON PSYCHIATRIC ADVERSE EVENTS FOR ALL ADHD DRUGS

Health Canada is informing Canadians that the prescribing and patient information for all drugs used for the management of ADHD (Attention Deficit Hyperactivity Disorder) is being revised to provide information about the potential for psychiatric adverse events, including rare reports of agitation and hallucinations in children. Health Canada (http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2006/2006_91_e.html)